Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Revolutionizing Pharmaceutical Ethics: UK’s ABPI Code of Practice Ushers in a New Era of Self-Regulation

The UK's ABPI Code of Practice is a pivotal self-regulatory framework guiding ethical conduct in the pharmaceutical industry. With upcoming updates in 2024, stakeholders are preparing for significant changes in operational and ethical standards. Key topics include the role of QR codes and enhancements to the signatory process.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Healthcare · Code ClarityDr. Joe DicapiteRina NewtonUk Abpi Code of Practice
Share
Revolutionizing Pharmaceutical Ethics: UK’s ABPI Code of Practice Ushers in a New Era of Self-Regulation

Key takeaways

01

The ABPI Code of Practice is crucial for ethical self-regulation in the UK pharmaceutical industry.

02

Anticipated 2024 updates will introduce validation requirements and streamline processes.

03

Innovative uses of QR codes in promotional materials will enhance accessibility.

In a dynamic era where the intersection of healthcare, regulation, and technology demands constant vigilance, the UK's ABPI Code of Practice stands as a testament to the pharmaceutical industry's commitment to self-regulation. Amidst a backdrop of historical challenges and technological advancements, this code serves as the rulebook guiding the ethical conduct of pharma companies within the UK. With the pharmaceutical landscape evolving at an unprecedented pace, the impending updates to the ABPI Code for 2024 have sparked a vital discussion on the balance between innovation, compliance, and patient safety.

The impending updates to the ABPI Code for 2024 have sparked a vital discussion on the balance between innovation, compliance, and patient safety.

What modifications can stakeholders expect in the 2024 iteration of the ABPI Code of Practice? How will these changes influence the operational and ethical frameworks of pharma companies in the UK?

Welcome to "Amend & Progress," a podcast brought to you by Vodori, dedicated to exploring the intricacies of promotional material review processes. Today, our host, Annalise Ludtke, delves into the anticipated updates to the UK's ABPI Code of Practice alongside two distinguished guests: Dr. Joe DiCapite, Director of Strategy for the UK and Europe at Vodori, and Rina Newton, co-founder of Code Clarity and a leading expert in code compliance.

In this enlightening conversation, they explore:

  • The essence and importance of the ABPI Code of Practice and its role in self-regulation.
  • The anticipated changes in the 2024 update, including the streamlining of the signatory process and the introduction of validation requirements for signatories.
  • The innovative use of QR codes in promotional materials to enhance access to prescribing information.

Dr. Joe DiCapite brings a wealth of experience in strategic planning and regulatory compliance, having extensively worked on navigating the complexities of the ABPI Code. Rina Newton, renowned for her expertise in code compliance, has played a pivotal role in shaping the dialogue around ethical practices within the pharmaceutical industry in the UK.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

About the author

H
Healthcare

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

NIH is harmonizing 12 petabytes of biomedical data to power the next wave of health AI

NIH is harmonizing 12 petabytes of biomedical data to power the next wave of health AI

The NIH is undertaking a cross-agency initiative to standardize 70 years of biomedical data, totaling 12 petabytes, to enhance health AI capabilities. This effort aims to establish a robust foundation for enterprise health IT leaders to deploy AI technologies effectively. By harmonizing this vast amount of data, the NIH is paving the way for significant advancements in health AI research and applications.

  • 01The NIH is standardizing 12 petabytes of biomedical data to advance health AI.
  • 02This initiative aims to create a robust foundation for AI deployment in healthcare.
  • 03Harmonizing historical biomedical data is critical for future health AI research.

Jul 24, 2026

ONC marks universal EHR adoption and one billion TEFCA health records exchanged in inaugural Coordinator's Quarterly

ONC marks universal EHR adoption and one billion TEFCA health records exchanged in inaugural Coordinator's Quarterly

The Office of the National Coordinator for Health Information Technology (ONC) has announced universal adoption of Electronic Health Records (EHR) across U.S. healthcare. Additionally, the Trusted Exchange Framework and Common Agreement (TEFCA) has facilitated the exchange of one billion health records. These milestones emphasize the significant progress in digital health record interoperability in the United States.

  • 01Universal adoption of Electronic Health Records (EHR) has been achieved across the U.S. healthcare system.
  • 02TEFCA has successfully facilitated the exchange of one billion health records.
  • 03These developments mark significant progress in the interoperability of digital health records.

Jul 23, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

H
Healthcare

Host, Amend & Progress

Annalise Ludtke hosts the 'Amend & Progress' podcast by Vodori, exploring updates and intricacies of pharmaceutical regulations. She facilitates discussions on material review processes and regulatory compliance alongside industry experts.

DJ
Dr. Joe DiCapite

Director of Strategy for the UK and Europe

Vidori

Dr. Joe DiCapite is a strategic planner and regulatory compliance expert with experience navigating the complexities of the ABPI Code. He plays a crucial role in adapting strategies for the UK and European markets.

RN
Rina Newton

Co-founder

Code Clarity

Rina Newton is a leading expert in code compliance, instrumental in shaping ethical dialogues in the UK pharmaceutical industry. She co-founded Code Clarity to enhance understanding of regulatory practices.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512